Scholar Rock Holding Corporation Common Stock

$51.49
USD
Last updated on --.
24h volume20.00
24h highest53.1210 USD
24h lowest52.0010 USD
24h Price movement-0.03%

SRRK recent prices

24 Hours
-0.03%-$0.015
30 days
+11.24%+$5.205
60 days
+12.98%+$5.530
90 days
+14.84%+$6.655

Key data

Previous close51.5100 USD
Market cap5.80B USD
Volume20.00
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.4100 USD
Net income (FY)-408.73M USD
Revenue (FY)--
Last report dateMay 7, 2026

About Scholar Rock Holding Corporation Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersCAMBRIDGE
Employees (FY)289.00
Net income per employee (FY)-1.41M USD
Listed onNasdaq
Official website

SRRK conversion tables

SRRKSRRK
USDUSD
0.5 SRRK25.74 USD
1 SRRK51.49 USD
5 SRRK257.47 USD
10 SRRK514.95 USD
USDUSD
SRRKSRRK
0.5 USD0.0097097 SRRK
1 USD0.019419 SRRK
5 USD0.097097 SRRK
10 USD0.19419 SRRK

FAQ

SRRK is trading at $51.49, -0.03% over the last 24 hours. Track live moves on the price chart at the top of this page.
The SRRK stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. SRRK is currently trading at $51.49, -0.03% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on SRRK price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. SRRK's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from SRRK; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against SRRK's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Scholar Rock Holding Corporation Common Stock's market cap is currently 5.80B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume20.00
24h highest53.1210 USD
24h lowest52.0010 USD
24h Price movement-0.03%
SRRKSRRK
USDUSD
Start trade with SRRK Perpetual